42 related articles for article (PubMed ID: 9886755)
1. Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats.
Fundytus ME; Yashpal K; Chabot JG; Osborne MG; Lefebvre CD; Dray A; Henry JL; Coderre TJ
Br J Pharmacol; 2001 Jan; 132(1):354-67. PubMed ID: 11156596
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effects of novel histamine H
Popiolek-Barczyk K; Łażewska D; Latacz G; Olejarz A; Makuch W; Stark H; Kieć-Kononowicz K; Mika J
Br J Pharmacol; 2018 Jul; 175(14):2897-2910. PubMed ID: 29486058
[TBL] [Abstract][Full Text] [Related]
3. Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management.
Eisenstein TK; Chen X; Inan S; Meissler JJ; Tallarida CS; Geller EB; Rawls SM; Cowan A; Adler MW
Mil Med; 2020 Jan; 185(Suppl 1):130-135. PubMed ID: 32074321
[TBL] [Abstract][Full Text] [Related]
4. Impact of ageing on the antinociceptive effect of reference analgesics in the Lou/c rat.
Jourdan D; Pickering G; Marchand F; Gaulier JM; Alliot J; Eschalier A
Br J Pharmacol; 2002 Nov; 137(6):813-20. PubMed ID: 12411412
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Drugs for Peripheral Nerve Blocks: The Role of NMDA Antagonists, Neostigmine, Epinephrine, and Sodium Bicarbonate.
Edinoff AN; Fitz-Gerald JS; Holland KAA; Reed JG; Murnane SE; Minter SG; Kaye AJ; Cornett EM; Imani F; Khademi SH; Kaye AM; Urman RD; Kaye AD
Anesth Pain Med; 2021 Jun; 11(3):e117146. PubMed ID: 34540646
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Modulation of Endogenous Opioid Activity to Attenuate Neuropathic Pain in Rats.
Liu NJ; Storman EM; Gintzler AR
J Pain; 2019 Feb; 20(2):235-243. PubMed ID: 30366152
[TBL] [Abstract][Full Text] [Related]
7. Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury.
Guan Y; Johanek LM; Hartke TV; Shim B; Tao YX; Ringkamp M; Meyer RA; Raja SN
Pain; 2008 Aug; 138(2):318-329. PubMed ID: 18276075
[TBL] [Abstract][Full Text] [Related]
8. Effects of sufentanil and NMDA antagonists on a C-fibre reflex in the rat.
Adam F; Gairard AC; Chauvin M; Le Bars D; Guirimand F
Br J Pharmacol; 2001 Aug; 133(7):1013-22. PubMed ID: 11487510
[TBL] [Abstract][Full Text] [Related]
9. Glutamate receptors and nociception: implications for the drug treatment of pain.
Fundytus ME
CNS Drugs; 2001 Jan; 15(1):29-58. PubMed ID: 11465012
[TBL] [Abstract][Full Text] [Related]
10. Combined systemic administration of the glycine/NMDA receptor antagonist, (+)-HA966 and morphine attenuates pain-related behaviour in a rat model of trigeminal neuropathic pain.
Christensen D; Gautron M; Guilbaud G; Kayser V
Pain; 1999 Dec; 83(3):433-440. PubMed ID: 10568851
[TBL] [Abstract][Full Text] [Related]
11. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes?
Wiesenfeld-Hallin Z
Drugs; 1998 Jan; 55(1):1-4. PubMed ID: 9463786
[TBL] [Abstract][Full Text] [Related]
12. Small molecules targeting the NMDA receptor complex as drugs for neuropathic pain.
Planells-Cases R; Pérez-Payá E; Messeguer A; Carreño C; Ferrer-Montiel A
Mini Rev Med Chem; 2003 Nov; 3(7):749-56. PubMed ID: 14529515
[TBL] [Abstract][Full Text] [Related]
13. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
[TBL] [Abstract][Full Text] [Related]
14. Complete prevention but stimulus-dependent reversion of morphine tolerance by the glycine/NMDA receptor antagonist (+)-HA966 in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Anesthesiology; 2000 Mar; 92(3):786-94. PubMed ID: 10719957
[TBL] [Abstract][Full Text] [Related]
15. The glycine/NMDA receptor antagonist (+)-HA966 enhances the peripheral effect of morphine in neuropathic rats.
Martinez V; Christensen D; Kayser V
Pain; 2002 Oct; 99(3):537-545. PubMed ID: 12406530
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
